LB-P7

N/A

Report date: 2024/12/18 13:39:48

Base Information

Drug NameLB-P7
Drug Alias NameLBP7
ClassificationBiologics
Mechanisms of ActionBacteria replacementsMicrobiome modulators
TargetsUpdating
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLISCure Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesLISCure Biosciences Inc
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A